Diabetes management software from Tandem gets FDA OK

02/28/2013 | San Diego Business Journal

The FDA has cleared Tandem Diabetes Care to market its t:connect diabetes management software. The technology, set to be released next month, provides diabetes patients and their doctors with electronic access to information from the company's t:slim insulin delivery systems and blood glucose monitors.

View Full Article in:

San Diego Business Journal

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA